When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Here's What Hepatitis C Actually Is—and How You Get It - AOL

   www.aol.com/lifestyle/heres-hepatitis-c-actually...

   In all cases, after just 12 weeks of treatment, 95 percent of people diagnosed with hepatitis C are cured. How to Prevent Hepatitis C Cured of hepatitis C, however, doesn’t mean immune.

3. Sofosbuvir - Wikipedia

   en.wikipedia.org/wiki/Sofosbuvir

   Sofosbuvir, sold under the brand name Sovaldi among others, is a medication used to treat hepatitis C. [3] It is taken by mouth. [3] [6]Common side effects include fatigue, headache, nausea, and trouble sleeping. [3]

4. Specialty drugs in the United States - Wikipedia

   en.wikipedia.org/wiki/Specialty_drugs_in_the...

   By 2014 the price of Gilead's specialty drug for hepatitis C, Sovaldi or sofosbuvir, was $84,000 to $168,000 for a course of treatment in the U.S., £35,000 in the UK for 12 weeks. [92] Sovaldi is on the World Health Organization's most important medications needed in a basic health system and the steep price is highly controversial.

5. Elbasvir/grazoprevir - Wikipedia

   en.wikipedia.org/wiki/Elbasvir/grazoprevir

   Elbasvir/grazoprevir, sold under the brand name Zepatier, is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor of hepatitis C virus's NS5A protein) and grazoprevir (an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and ...

6. Understanding hepatitis C: A growing public health concern - AOL

   www.aol.com/news/understanding-hepatitis-c...

   Mar. 14—Hepatitis C is a liver infection caused by the hepatitis C virus. It is becoming a big public health concern in many counties, including Lawrence County, encouraging us to review some ...

7. Telaprevir - Wikipedia

   en.wikipedia.org/wiki/Telaprevir

   Telaprevir (VX-950), marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors . [ 3 ]